-
-
-
-
-
-
-
Legendary Investors are Rotating Capital into AI Powered Biotech
-
-
-
-
-
-
-
CRISPR Therapeutics' (CRSP) BEAM Risto-Cel Data Competitive - Citizens
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform on CRISPR (CRSP), Notes In-vivo Editing Progress
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) PT Raised to $56 at Barclays
-
-
-
-
-
-
-
Brookline Capital Markets Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
-
-
-
-
-
-
-
Eli Lilly and Verve's gene-editing M&A deal 'an important milestone' - Citizens JMP
-
415,984 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

